1.Primary gastrointestinal malignant lymphoma:a clinical analysis in 36 cases
Chinese Journal of Primary Medicine and Pharmacy 2006;0(07):-
Objective To investigate the clinical characteristics,diagnosis and treatment of primary gastroin- testinal malignant lymphoma(PGML).Methods Twenty-two PGML patients were collected from January 1999 to December 2004,and their clinical characteristics,diagnosis,treatment and prognosis were analyzed,Results Among the 22 cases,PGMI commonly attacked stomach,ileocecal region and colon respectively,and the main clinical mani- festations were abdominal pain and bloody stools.50 % of the patients were confirmed by endoscopic biopsy.The pa~ tients treated by operation and chemotherapy turned to better to different extents.Conclusion PGML lacks specific manifestations,thus it has higher rate of misdiagnosis.There are good responses to the assistant chemotherapy and radiotherapy.
2.Optimum packing technology of volatile oil in Rukang Capsule by uniform test
Kongyun WU ; Wenyuan GAO ; Guangyi LIANG
Chinese Traditional and Herbal Drugs 1994;0(08):-
Object To study the suitable conditions for the pac king of volatile oil in Rukang Capsule, which will inhibit the loss of volatile oil. Methods With the packing rate as index, even design method wa s applied to investigate the optimal packing conditions. Results The optimal packing conditions were found to be: volatile oil volume (mL)-cy c lodextrin (g)=1∶6, the packing process should be carried out for 120 min under 40 ℃. Conclusion The repetition rate is very good in the repeti tion experiments.
3.The effect of human complement C_(5b~9) complex on nitric oxide synthesis in glomerular mesangial cells of rats
Yingwei WANG ; Qiuzao HE ; Huilian QIN ; Renxian TANG ; Fengguang GAO ; Guangyi ZHANG
Chinese Journal of Pathophysiology 1986;0(03):-
AIM:To study the effect of human complement C 5b~9 complex on nitric oxide(NO) synthesis of glomerular mesangial cells (MC). METHODS: First, the human complement C 5b~9 complexes were isolated and glomerular MC of rats were cultured. Second, the MC were stimulated with C 5b~9 complex and changes of metabolism products of NO(NO 3 and NO 2) in MC culture supernatant at 6,24 and 48 hours after C 5b~9 stimulating were detected. Moreover, cGMP levels in cultured MC were also measured. RESULTS: NO 3/NO 2 contents from culture supernatant and cGMP levels in MC were increased parallelly after C 5b~9 complex stimulation. Further, NO synthesis was inhibited by L-NG-nitro-arginine-methylester(L-NAME). CONCLUSION: NO synthesis of rat glomerular MC was incerased by human complement C 5b~9 stimulation.
4.Synergistic anti-proliferation effect of aspirin and 5-fluorouracil on colon cancer cells and its mechanism
Yu LIU ; Dong GAO ; Jingjing ZHONG ; Yanyan WAN ; Xiangying LI ; Guangyi JIN ; Xiaodong WANG
Chinese Journal of Pathophysiology 2014;(6):988-993
AIM:To investigate the synergistic anti-proliferation effect of aspirin and 5-fluorouracil on the co-lon cancer cells and its mechanism .METHODS: Colon cancer cells were divided into 4 groups: control group , aspirin group, 5-fluorouracil group and aspirin +5-fluorouracil group .Synergistic anti-proliferation effect of aspirin and 5-fluoroura-cil on the colon cancer cells was observed by MTT assay .Apoptosis-inducing effect and mechanism were detected by Hoechst 33258 staining, caspase activity assay and flow cytometry analysis .The mRNA and protein levels of apoptosis-re-lated proteins were evaluated by real-time PCR and Western blotting .RESULTS:5-Fluorouracil inhibited proliferation of HCT116 and SW620 colon cancer cells effectively , and low concentration of aspirin exerted synergistic inhibitory effect .5-Fluorouracil induced apoptotic morphology and increased caspase activity and sub -G1 phase in HCT116 cells.The synergis-tic effect of aspirin obviously enhanced apoptotic ratio and caspase activity .Moreover , 5-fluorouracil inhibited the mRNA and protein expression of Bcl-2, which was amplified by low concentration of aspirin .CONCLUSION:Aspirin and 5-flu-orouracil had a synergistic anti-proliferation effect on the colon cancer cells through apoptosis pathway .
5.Studies on the Chemical Constituents of Largesepal
Youheng GAO ; Ying ZHU ; Zhenxian WAN ; Guangyi LI ; Wushunhua ; Kaifu YU ; Guosheng LIU ;
Chinese Traditional and Herbal Drugs 1994;0(05):-
Six compounds were isolated from the dried leaves and tender branches of Rabdosia ma-crocalyx (Dunn ) Hara. Their structures were identified as excisanin A, excisanin B, rabdol-oxin B, ursolic acid, ?-sitosterol and palmitic acid.
6.Research progress of immune checkpoint inhibitors in the treatment of lung cancer
Jun MA ; Hongying ZHANG ; Aiping WU ; Guangyi GAO
Journal of International Oncology 2021;48(11):683-687
In recent years, immune checkpoint inhibitors are a milestone in the treatment of lung cancer. There are many kinds of immune checkpoints, which are closely related to the efficacy and drug resis-tance of immunotherapy, including programmed death-1 (PD-1), programmed death ligand-1 (PD-L1), cytotoxic T-lymphocyte antigen 4 (CTLA-4), killer cell immunoglobulin-like receptor (KIR), T cell immunoglobulin and ITIM domain (TIGIT), T-cell immunoglobulin and mucin domain-containing protein 3 (TIM-3), etc. PD-1/PD-L1 inhibitors have been approved by China National Medical Products Administration and U. S. Food and Drug Administration for the first-line treatment of lung cancer, which can improve overall survival and progression-free survival of patients. The double immunotherapies of CTLA-4 inhibitors or TIGIT inhibitors combined with PD-1/PD-L1 inhibitors also achieve good results, however, more serious adverse events may occur.The KIR and TIM-3 targets are closely related to the drug resistance of immunotherapy.
8.Surgical site infection following abdominal surgery in China: a multicenter cross-sectional study.
Zhiwei WANG ; Jun CHEN ; Jianan REN ; Peige WANG ; Zhigang JIE ; Weidong JIN ; Jiankun HU ; Yong LI ; Jianwen ZHANG ; Shuhua LI ; Jiancheng TU ; Haiyang ZHANG ; Hongbin LIU ; Liang SHANG ; Jie ZHAO ; Suming LUO ; Hongliang YAO ; Baoqing JIA ; Lin CHEN ; Zeqiang REN ; Guangyi LI ; Hao ZHANG ; Zhiming WU ; Daorong WANG ; Yongshun GAO ; Weihua FU ; Hua YANG ; Wenbiao XIE ; Erlei ZHANG ; Yong PENG ; Shichen WANG ; Jie CHEN ; Junqiang ZHANG ; Tao ZHENG ; Gefei WANG
Chinese Journal of Gastrointestinal Surgery 2018;21(12):1366-1373
OBJECTIVE:
To determine the incidence of surgical site infection (SSI) after abdominal surgery and to further evaluate the related risk factors of SSI in China.
METHODS:
The multicenter cross-sectional study collected clinical data of all adult patients who underwent abdominal surgery from May 1, 2018 to May 31, 2018 in 30 domestic hospitals, including basic information, perioperative parameters, and incisional microbial culture results. The primary outcome was the incidence of SSI within postoperative 30 days. SSI was classified into superficial incision infection, deep incision infection, and organ/gap infection according to the US Centers for Disease Control and Prevention (CDC) criteria. The secondary outcome variables were ICU stay, postoperative hospital stay, total hospital stay, 30-day mortality and treatment costs. Multivariate logistic regression was used to analyze the risk factors of SSI.
RESULTS:
A total of 1666 patients were enrolled in the study, including 263 cases of East War Zone Hospital of PLA, 140 cases of Affiliated Hospital of Qingdao University, 108 cases of The First Affiliated Hospital of Nanchang University, 87 cases of Central War Zone Hospital of PLA, 77 cases of West China Hospital, 74 cases of Guangdong General Hospital, 71 cases of Chenzhou First People's Hospital, 71 cases of Zigong First People's Hospital, 64 cases of Zhangjiagang First People's Hospital, 56 cases of Nanyang City Central Hospital, 56 cases of Lanzhou General Hospital of Lanzhou Military Command, 56 cases of Shandong Provincial Hospital, 52 cases of Shangqiu First People's Hospital, 52 cases of People's Hospital of Xinjiang Uygur Autonomous Region, 48 cases of The Second Xiangya Hospital of Central South University, 48 cases of Chinese PLA General Hospital, 44 cases of Affiliated Hospital of Xuzhou Medical University, 38 cases of Hunan Province People's Hospital, 36 cases of Dongguan Kanghua Hospital, 30 cases of Shaoxing Central Hospital, 30 cases of Northern Jiangsu People's Hospital, 29 vases of The First Affiliated Hospital of Zhengzhou University, 27 cases of General Hospital of Tianjin Medical University, 22 cases of Zigong Fourth People's Hospital, 21 cases of The Second Hospital of University of South China, 18 cases of Tongji Hospital, 15 cases of Nanchong Central Hospital, 12 cases of The 901th Hospital of PLA, 11 cases of Hunan Cancer Hospital, 10 cases of Lanzhou University Second Hospital. There were 1019 males and 647 females with mean age of (56.5±15.3) years old. SSI occurred in 80 patients (4.8%) after operation, including 39 cases of superficial incision infection, 16 cases of deep incision infection, and 25 cases of organ/interstitial infection. Escherichia coli was the main pathogen of SSI, and the positive rate was 32.5% (26/80). Compared with patients without SSI, those with SSI had significantly higher ICU occupancy rate [38.8%(31/80) vs. 13.9%(220/1586), P<0.001], postoperative hospital stay (median 17 days vs. 7 days, P<0.001) and total hospital stay (median 22 days vs. 13 days, P<0.001), and significantly higher cost of treatment (median 75 000 yuan vs. 44 000 yuan, P<0.001). Multivariate analysis showed that male rise(OR=2.110, 95%CI:1.175-3.791, P=0.012), preoperative blood glucose level rise(OR=1.100, 95%CI: 1.012-1.197, P=0.026), operative time (OR=1.006, 95%CI:1.003-1.009, P<0.001) and surgical incision grade (clean-contaminated incision:OR=10.207, 95%CI:1.369-76.120, P=0.023; contaminated incision: OR=10.617, 95%CI:1.298-86.865, P=0.028; infection incision: OR=20.173, 95%CI:1.768-230.121, P=0.016) were risk factors for SSI; and laparoscopic surgery (OR=0.348, 95%CI:0.192-0.631, P=0.001) and mechanical bowel preparation(OR=0.441,95%CI:0.221-0.879, P=0.020) were protective factors for SSI.
CONCLUSIONS
The incidence of postoperative SSI in patients with abdominal surgery in China is 4.8%. SSI can significantly increase the medical burden of patients. Preoperative control of blood glucose and mechanical bowel preparation are important measures to prevent SSI.
Abdomen
;
surgery
;
Adult
;
Aged
;
China
;
Cross-Sectional Studies
;
Female
;
General Surgery
;
statistics & numerical data
;
Humans
;
Male
;
Middle Aged
;
Operative Time
;
Postoperative Complications
;
prevention & control
;
Preoperative Period
;
Retrospective Studies
;
Risk Factors
;
Surgical Wound Infection
;
prevention & control